文献速递脑血管病外科神经重症

PD-1+单核细胞介导蛛网膜下腔出血后脑血管痉挛

PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage.
PubMed 文献 · Neurosurgery · 2021-01-01

该研究在小鼠中采用颈内动脉穿孔诱导脑血管痉挛,发现给予PD-L1可阻止活化Ly6c+和CCR2+单核细胞进入脑内从而预防痉挛。在破裂动脉瘤患者中,外周血PD-1+单核细胞频率与脑血流速度和临床血管痉挛相对应,提示PD-1激动可能成为新治疗策略。

要点

  • PD-L1给药可预防小鼠脑血管痉挛,机制与抑制炎性单核细胞脑内浸润相关
  • 破裂动脉瘤患者外周血PD-1+单核细胞与经颅多普勒速度和临床痉挛相关
  • PD-1激动被提出作为脑血管痉挛的新型治疗策略

核心结论

  • PD-1+单核细胞是脑血管痉挛的介导细胞,支持PD-1激动作为新型治疗策略。

研究设计与样本

  • 小鼠采用颈内动脉穿孔诱导脑血管痉挛,并在穿孔后1小时给予PD-L1。
  • 患者队列中从外周血分离单核细胞,用流式细胞术分析破裂脑动脉瘤患者的PD-1+单核细胞。

主要发现

  • PD-L1给药通过抑制活化Ly6c+和CCR2+单核细胞进入脑内而预防脑血管痉挛。
  • 破裂动脉瘤患者外周血存在PD-1+单核细胞,其频率与脑血流速度和临床血管痉挛相对应。

临床怎么用

  • PD-1+单核细胞频率或可作为破裂动脉瘤后血管痉挛的相关生物标志物。
  • 靶向PD-1通路可能成为预防脑血管痉挛的潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral vasospasm is a major source of morbidity and mortality following aneurysm rupture and has limited treatment options. OBJECTIVE: To evaluate the role of programmed death-1 (PD-1) in cerebral vasospasm. METHODS: Endovascular internal carotid artery perforation (ICAp) was used to induce cerebral vasospasm in mice. To evaluate the therapeutic potential of targeting PD-1, programmed death ligand-1 (PD-L1) was administered 1 h after ICAp and vasospasm was measured histologically at the level of the ICA bifurcation bilaterally. PD-1 expressing immune cell populations were evaluated by flow cytometry. To correlate these findings to patients and evaluate the potential of PD-1 as a biomarker, monocytes were isolated from the peripheral blood and analyzed by flow cytometry in a cohort of patients with ruptured cerebral aneurysms. The daily frequency of PD-1+ monocytes in the peripheral blood was correlated to transcranial Doppler velocities as well as clinical and radiographic vasospasm. RESULTS: We found that PD-L1 administration prevented cerebral vasospasm by inhibiting ingress of activated Ly6c+ and CCR2+ monocytes into the brain. Human correlative studies confirmed the presence of PD-1+ monocytes in the peripheral blood of patients with ruptured aneurysms and the frequency of these cells corresponded with cerebral blood flow velocities and clinical vasospasm. CONCLUSION: Our results identify PD-1+ monocytes as mediators of cerebral vasospasm and support PD-1 agonism as a novel therapeutic strategy.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Jackson CM, Choi J, Routkevitch D, et al. PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage. Neurosurgery. 2021. PMID: 33370819. doi:10.1093/neuros/nyaa495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。